₹-3.20
(Market cap
₹215 Cr
Recently Viewed
Clear AllMarket cap
₹215 Cr
Revenue (TTM)
₹85 Cr
P/E Ratio
20.6
P/B Ratio
3
Div. Yield
1.2 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹10 Cr
ROE
14.5 %
ROCE
18.2 %
Industry P/E
27.55
EV/EBITDA
12
Debt to Equity
0
Book Value
₹126.4
EPS
₹18.1
Face value
10
Shares outstanding
5,757,300
CFO
₹42.11 Cr
EBITDA
₹82.82 Cr
Net Profit
₹62.03 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BDH
| -11.7 | -0.3 | -8.6 | 39.7 | 46.2 | 34.0 | 16.9 |
|
BSE Healthcare
| -2.4 | -2.6 | -3.9 | 5.9 | 24.1 | 13.8 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
BDH
| 22.1 | 35.3 | 43.3 | 13.0 | 62.2 | 27.9 | -3.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BDH
|
375.8 | 215.0 | 84.7 | 10.4 | 14.0 | 15 | 20.6 | 3.0 |
| 2,751.0 | 34,358.6 | 5,201.6 | 1,014.6 | 22.9 | 25 | 33.9 | 7.5 | |
| 8,051.0 | 20,145.0 | 2,177.5 | 200.9 | 11.3 | 26.5 | 100.3 | 24.2 | |
| 1,662.0 | 12,595.9 | 2,089.5 | 622.0 | 31.3 | 20.4 | 20.5 | 3.8 | |
| 1,364.1 | 18,913.9 | 3,078.2 | 469.4 | 26.4 | 14.9 | 43.8 | 5.2 | |
| 1,970.2 | 31,628.5 | 4,193.0 | 753.8 | 22.7 | 20.8 | 42 | 7.9 | |
| 4,749.1 | 21,777.1 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.5 | 5.5 | |
| 4,802.1 | 7,975.2 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27.2 | 11.4 | |
| 419.0 | 8,183.1 | 1,432.0 | 149.0 | 19.1 | 7.9 | 54.5 | 3.3 | |
| 996.3 | 9,169.8 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.9 | 3.1 |
No Review & Analysis are available.
BDH Industries Limited manufactures and sells therapeutic formulations covering a range of pharmaceuticals in India. It offers analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics,... anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcer pharmaceutical products. The company also provides antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products. In addition, it offers skin protectives, skin smootheners, and vitamins, as well as SOULFIL, an oral pill for the treatment of erectile dysfunction in men. The company exports its products to the United States, Canada, Latin America, the Caribbean Islands, Europe, Russia, Gulf Countries, Australia, African countries, Asia, and Far East countries. BDH Industries Limited was founded in 1935 and is based in Mumbai, India. Read more
Incorporated
1990
Chairman
Jayashree Nair
Managing Director
Jayashree Nair
Headquarters
Mumbai, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of BDH Industries Ltd is ₹375.80 (BSE) and ₹1.30 (NSE) as of 09-Apr-2026 IST. BDH Industries Ltd has given a return of 46.24% in the last 3 years.
The P/E ratio of BDH Industries Ltd is 20.63 times as on 09-Apr-2026, a 25 discount to its peers’ median range of 27.55 times.
The P/B ratio of BDH Industries Ltd is 2.95 times as on 09-Apr-2026, a 35 discount to its peers’ median range of 4.52 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
16.33
|
2.24
|
|
2024
|
16.45
|
2.67
|
|
2023
|
7.92
|
1.22
|
|
2022
|
10.66
|
1.63
|
|
2021
|
8.36
|
1.28
|
The 52-week high and low of BDH Industries Ltd are Rs 523.75 and Rs 241.00 as of 09-Apr-2026.
BDH Industries Ltd has a market capitalisation of ₹ 215 Cr as on 09-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in BDH Industries Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.